Powered by whole-genome sequencing and MAESTRO* technology, the next-generation Oncodetect test takes a distinct approach to MRD,...
GrOwnValve GmbH, a Berlin-based medical technology company developing personalized heart valves from patients' own tissue, announced the achievement of t...
Made Scientific to integrate multiple UniFuge® single-use centrifugation systems across its Princeton, NJ, and East Norriton, PA, facilities to suppo...
Golden Age Health is co-founded and chaired by Michel Vounatsos, former Biogen CEO and Merck President Kos Biotechnology Partners ("Kos"), a global ...
As demand for injectable therapies grows and manufacturing requirements become more complex, Vetter Pharma is expanding its global fill-finish network to...
Biopharma Boardroom speaks with Dr Anthony Bradley, Co-Founder and Chief Scientific Officer at DaltonTx, about how the company is b...
Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), and Acesion Pharma, a Copenhagen-base...
Strategic investments strengthen resilience and service capabilities for innovative injectable therapies First of ten additional commercial ma...
NanoImaging Services, a cryo-EM CRO, and Proteos, a protein production research partner, have announced the launch of TrueCourse Biosciences, an in...
Bioiberica, a global life science company, announces its return to CPHI Milan with a renewed mission to provide the high-quality, traceable and scientifi...
Andelyn Biosciences (“Andelyn”), a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (&ldqu...
Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), reported interim results from a clinical st...
Symbiosis Pharmaceutical Services is entering a new phase of growth following a £26 million investment to expand its ...
As biologics and novel modalities become increasingly sophisticated, understanding molecular structure under controlled conditions tells only part ...
© 2026 Biopharma Boardroom. All Rights Reserved.
